Acute coronary syndrome and OSAHS an unequivocal association (prospective study)

B. Conde, T. Calvo, P. Fontes, A. Afonso, I. Moreira (Vila Real, Portugal)

Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Abstract

The Obstructive Sleep Apnea/Hypopneia Syndrome (OSAHS) of increasing prevalence in recent years, is predominant in middle aged men (24% in males versus 9% in females), with an even higher prevalence in risk groups (50%).
Objective: to assess the prevalence of OSAHS in patients hospitalized for Acute Coronary Syndrome (ACS).
Material and Methods: a prospective randomized study, applying clinical protocol of investigation, for ACS and OSAHS. Selecting the 1st patient of the day (from 0 to 24 hours) admitted with ACS for the study of a possible OSAHS, with Cardiorespiratory sleep study (Stardust ® II), performed after stabilization, and confirmed later by Polysomnography (PSG) (Alice® 4), being held between 1 and 2 months after. Research was made after the patient‘s informed consent. Data processed with SPSS version 16.
Results: eighty-eight patients were included over a period of 1 year, October 2007 to November 2008, with 65 males (73.9%) and a mean age of 58 years (Max.75: Min.37). Population with mean BMI of 27.4 kg/m2 (Max.41, 7: Min.20, 6). Only 73 patients conclued the investigation protocol, that was compatible with the existence of OSAHS in 46 cases (63%), classifying it as severe in 21 (28,8%) cases (AHI> 30/h). The obesity and diastolic dysfunction predominant in OSAHS group, diferences statistically significant. It therapeutic CPAP, auto-ajusted CPAP or Pressure support servo-ventilation was established, according to the clinical situation, in 36 cases.
Conclusion: the high prevalence of OSAHS in this population, which the current study allowed to diagnose and treat, seems to make the point that it is justified to include the cardiorespiratory sleep study in investigation of ACS patients.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Conde, T. Calvo, P. Fontes, A. Afonso, I. Moreira (Vila Real, Portugal). Acute coronary syndrome and OSAHS an unequivocal association (prospective study). Eur Respir J 2010; 36: Suppl. 54, 908

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of obstructive sleep apnoea on cardiovascular outcomes in patients with acute coronary syndrome: a secondary analysis of the RICCADSA trial
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020



Timely association between obstructive sleep apnea (OSA) and cardiovascular outcome after first acute myocardial infarction (AMI): A national wide population-based study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Prevalence of obstructive sleep apnoea in patients with thoracic aortic aneurysm: A prospective, parallel cohort study.
Source: International Congress 2019 – Epidemiology, genetics, air pollution and sleep
Year: 2019


Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019

Standard chest radiographs in patients admitted for evaluation of acute coronary syndrome may contribute to early recognition of pulmonary disease, an observational study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014


Obstructive sleep apnea as risk factor for incident metabolic syndrome: a multicentric prospective epidemiological study
Source: International Congress 2018 – Epidemiology, phenotypes and cardiometabolic comorbidities of obstructive sleep apnoea
Year: 2018



Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study.
Source: International Congress 2018 – Sleep-disordered breathing: cardiovascular consequences, epidemiology, phenotypes and comorbidities
Year: 2018



Is obstructive sleep apnea a risk factor for the progression of thoracic aortic aneurysm? A prospective cohort study
Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders
Year: 2020




Association between obstructive sleep apnoea (OSA) and risk of systemic hypertension in men. A prospective study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003

Obstructive sleep apnoea as a risk factor for incident metabolic syndrome: a joined Episono and HypnoLaus prospective cohorts study
Source: Eur Respir J, 52 (5) 1801150; 10.1183/13993003.01150-2018
Year: 2018



Sleep apnea syndrome in patients with stable chronic heart failure: Preliminary results of an Austrian pilot study
Source: Annual Congress 2010 - Sleep apnoea: insights from animal models and diagnostic tools
Year: 2010

Metabolic syndrome is associated with increased risk of acute exacerbation of COPD: A preliminary study
Source: Annual Congress 2010 - COPD: comorbidities
Year: 2010


Monocyte count/HDL cholesterol ratio and cardiovascular disease in patients with obstructive sleep apnea syndrome; a multicenter study
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017

Ventilatory phenotypes of sleep apnoea subtypes at a chronic delay following a first ischemic stroke: a cross-sectional analysis of a prospective clinical-based cohort study
Source: Sleep and Breathing Conference 2021
Year: 2021




Moderate obstructive sleep apnea and cardiovascular outcomes in elder patients: a propensity score matched, multicentric study (CPAGE-MODE study)
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Year: 2021



FACE: A prospective multicentre observational cohort study in patients with chronic heart failure (CHF) and central sleep apnoea (CSA) treated with adaptive servoventilation (ASV)
Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing
Year: 2013


Screening of sleep apnea syndrome in patients with acute coronary syndrome
Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease
Year: 2010


A study on the association between the severity of newly diagnosed obstructive sleep apnea and subclinical carotid atherosclerosis in patients without overt cardiovascular disease
Source: International Congress 2016 – Hypoxia, oxidative stress, and biomarkers in obstructive sleep apnoea
Year: 2016

Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006

Gout increases the risk of coronary heart disease among patients with obstructive sleep apnea: A nationwide population-based cohort study
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015